UMB School of Medicine

UMB School of Medicine Biochemistry & Molecular Biology

 Adil E. Shamoo, Ph.D.

Education

Experiences

Societies Honor
& Professional

Journals,
Editorals, etc.

Books &
Publications

Department of Biochemistry & Molecular Biology
 University of Maryland Baltimore
 108 N. Greene Street
 Baltimore MD 21201

Born: August 1, 1941
 Tel. (410)706-3327 (work)
 FAX (410) 706-3189
 e-mail: ashamoo@umaryland.edu

Dr. Shamoo is the founder and Editor-in-Chief (since 1988) of the journal, Accountability in Research and a member of several editorial boards among them the Drug Information Journal (2005-present). He was a member of the National Human Research Protections Advisory Committee (NHRPAC, 2000-2002). A research scientist with an extensive publication record, he is currently a professor and former chairman of the Department of Biochemistry and Molecular Biology, professor (secondary) of Epidemiology and Preventive Medicine, and a member of the graduate faculty of Applied Professional Ethics, and affiliated with the Center for Biomedical Ethics at the University of Maryland, Baltimore. He also chaired in 2003 a Special Issue GlaxoSmithKline Pharamaceuticals’ Ethics Advisory Group. Dr. Shamoo was appointed to Armed Forces Epidemiological Board (AFEB) of DOD as the ethics consultant (2003-2004). Dr. Shamoo has been teaching since 1991 a graduate course on: “Responsible Conduct of Research.” He chaired nine international conferences on ethics in research and human research protections and testified on this issue before Congressional Committees and the National Bioethics Advisory Commission. He chairs (2004-2006) the Ethics and Regulatory Forum of the Association of Clinical Reseach Professionals (ACRP). Dr. Shamoo served on numerous local and national boards and councils.         

Dr. Shamoo has lectured on all of these topics worldwide. Dr. Shamoo has held visiting professorships in such notable institutions as the Institute for Political Studies in Paris, France and East Carolina University. He works with industry and start-up companies, research institutions, and government agencies. He provides training, education, and workshops on Human Research Protections (HRP), patient recruitment, and Responsible Conduct in Research (RCP). Dr. Shamoo co-authored a textbook in 2003 titled: Responsible Conduct of Research (with David Resnik, Ph.D.). He also co-authored in 2002 a monograph titled: Ethics of the Use of Human Subjects in Research (with Felix Gyi, Pharm. D.).

Dr. Shamoo has been cited and/or appeared frequently in local and national media both print and television.


Education:  top

10/2/01

Certificate of IRB Professional (CIP) by Council for Certification of IRB Professionals.

7/12/98-7/17/98

Patent Review Course, Patent Resources Group, Inc.

9/5/92-12/12/92

Certificate, "Regulatory Issues in Biotechnology", Office of Continuing Education, University of Maryland Baltimore County.

1/11/91-1/22/91

Molecular Biology Techniques, Medical Biotechnology Center, University of Maryland at Baltimore.

9/68-1/70

Ph.D. (Biophysics) Ph.D. Program in Biology of the City University of New York, New York, N.Y. Thesis: Intermediary Reactions Involving (Na + K)-dependent ATPase. Advisor: Dr. William A. Brodsky

1/67-6/68

Graduate Studies in Biophysics. Dept. of Physiology and Biophysics, Louisville, KY.

6/64-1/66

M.S. - (Physics) University of Louisville, Louisville, KY. Thesis: Tellurium Films in Modulated Electric Field. Advisor: Dr. Manuel Schwartz, Head of Engineering Physics Dept.

9/58-6/62

B.Sc. - (Physics) University of Baghdad, Baghdad, Iraq.


Experience:  top

10/3 - Present

Professor (Secondary) in the Departement of Epidemiology and       Preventive Medicine.

10/2003-8/2004

Appointed to Armed Forces Epidemiological Board (AFEB) of DOD as the ethics consultant.

3/2003 - 3/2004

Chair, the Special Issue GlaxoSmithKline Pharamaceuticals’ Ethics Advisory Group.

1/02-present

Consultant, Friends Research Institute (FRI) Baltimore, MD.

12/2000-present

Member, National Human Research Protections Advisory Committee (NHRPAC)

7/82-present

Professor, and former Chairman (79-82) Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD.

7/98-present

Member, Center for Biomedical Ethics, University of Maryland, Baltimore

7/98-present

Member, University of Maryland, Baltimore Graduate Faculty in Applied Professional Ethics.

12/96 - 12/99

Adjunct Professor, Department of Physics, East Carolina University, Greenville, North Carolina.

1/1/97 - 1/1/2000

Member, Board of Directors, Howard County Mental Health Authority (quasi - public agency), Interim Chairman of the board (elected position) 2/1/97-5/20/97

5/20/97-7/99

President (Elected annually) of the Board of Directors of Howard County Mental Health Authority, Acted as Executive Director from 2/97 to 12/97.

7/95 - 9/95

Visiting Professor, Institute of Political Studies of Paris, National Political Science Foundation, Paris, France.

7/94-6/97

Member of the Board of Directors of the National Alliance for the Mentally Ill, (Elected Position).

3/95-present

Member, Advisory Board, Science for Professionals, Inc.

5/94-present

Member of the Board of Directors of "Friends Research Institute, Inc." Baltimore, MD, a national research and philanthropic organization.

6/93-6/94

President, Faculty Senate, University of Maryland at Baltimore.

7/92-7/94

Member, Center for Biomedical Ethics, University of Maryland at Baltimore.

1/89-present

Private Consultant in Biotechnology Research: Planning, Evaluation and Quality Management.

1/88-1992

Consultant and Member of Board of Scientific Advisors, Bionix Corporation, Potomac, MD.

1/91-1/93

Guest Professor, Department of Clinical Pathology, Department of Experimental Medicine, L'aquila University, L'aquila, Italy.

7/88-10/88

Expert, Laboratory of Theoretical Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD.

7/75-6/79

Associate Professor, Radiation Biology and Biophysics, University of Rochester School of Medicine & Dentistry, Rochester, NY.

8/77-2/78

Guest Professor, Max-Planck Institute for Biophysics, Frankfort, West Germany (Director, Dr. Karl Ullrich).

Summer, 1976

Guest Professor for two months at the Max-Planck institute for Biophysics, Frankfort, West Germany (Director, Dr. Karl Ullrich).

11/76-4/77

Consultant to Kodak Company-Division of Biological Sciences, Rochester, NY

7/73-6/75

Assistant Professor, Radiation Biology and Biophysics, University of Rochester, School of Medicine and Dentistry, Rochester, NY.

5/72-6/73

Guest Worker, Laboratories of Biophysics and Neurochemistry, National Institutes of Health, Bethesda, MD.

2/72-6/73

Member of the Graduate Faculty, Ph.D. Program in Biomedical Sciences, Graduate Center of the City University of New York, New York, NY.

7/71-6/73

Assistant Professor of Physiology, Mount Sinai School of the City University of New York, New York, NY.

7/68-6/71

Associate of Biophysics in Department of Physiology and Graduate School of the City University of New York, New York, NY.

6/68-7/70

Assistant of Biophysics, Mount Sinai Graduate School of Biological Sciences (CUNY), New York, NY.

6/65-6/68

Instructor at Engineering Physics Department, Speed School, University of Louisville, Louisville, KY.

OFFICES, ORGANIZING COMMITTEES,HONORS AND WORKSHOPS

 

8/95 - Present

Founder and a member of board of directors of: Citizens for Responsible Care and Research (CIRCARE), a national human rights organization.

2/2005 - Present

Member of Partnership for Human Research Protection (PHRP), Public Advisory Council.

7/2004 - Present

 Member of the Advisory Board on Master Program in Research Ethics at Sarah Lawrence College, Bronxville, NY.

7/2004 - 2/2005

Member of the Planning Committee of Sarah Lawrence College sponsored conference on: Health Advocates in Research held on Jan 14, 2005.

5/04 – 5/2006

Chair, Ethics and Regulatory Forum of the Association of Clinical Research Professionals (ACRP).

10/2003 - 6/2004

Member of the planning Committee for the conference sponsored by OHRP/FRI/F A&M University in Orlando, Florida, March 30- April 2 , 2004.

11/2001 - 10/2002

Coordinator for Award in Excellence for Health Improvement Institute.

9/2002 - 10/2004

Judge for the Innovation award for the Award of Excellence for Health Improvement Institute.

2/2002 - 12/2002

Member of the Planning Committee of the Conference Sponsored by the Office of Research Integrity entitled: Research on Research Integrity, November 16-18, 2002, Rockville, MD.

10/21/2002

Chairman, FRI’s Human Research Protections Workshop, Washington, DC.

6/1/02

Executive Secretary and Founder of the Friends Research Institute’s Research Ethics Award.The award amount is for $10,000 to be awarded annually at the FRI’s National Ethics Conferences with a plaque.

1/1/98-1/2002

Member, Award Committee of Friends Research Institute (FRI) Inc.

11/2000-10/2002

Member, Workgroup on “Financial Relationship,” National Human Research, Protections Advisory Committee (NHRPAC).

5/5/2002

Chairman, FRI’s Workshop on Human Research Protections, San Francisco, California

6/1/2001-Present

Member, Quality Improvement Committee (QIC) of Friends Research Institute FRI) Inc.It oversees all research quality issues in addition to the two Institutional Review Boards (IRBs).

3/2001

Co-chairman, National Conference on:“Ethics of the Use of Children in Research,” May 5-7, 2002, San Francisco, California.

2/2001

Awarded Friends Research Institute’s Leadership in Ethics in Research Conferences.

2/2000-6/2000

Worked with Congressional staff of Congressman Diana DeGette and Dennis Kucinich on Human Subject Protection Action 2000.

2/8/00-2/8/00

A member of a focus group sponsored by ORI for training and education in research integrity.

5/2000

Awarded Distinguished Service Award from the Howard County Mental Health Authority, Columbia, Maryland.

5/1/2000

Certificate of Recognition from Howard County Executive for serving on the board of directors of Howard County Mental Health Authority.

4/30/2000

A one day workshop on “Ethics of the Use of Human Subjects in Research” in Collaboration with Chesapeake Research Review, Inc., for Friends Research Institute, Towson, Maryland.

6/99-Present

Co-Chairman, National Conference on: “The Business of Human Experiments: ethical, legal, and regulatory issues,” to be held November 3-5, 2000 in Baltimore, Maryland.

11/18/99-11/19/99

Member of the Planning Group on Research on Research Integrity (RRI), convened by the Office of Research Integrity (ORI) Bethesda, Maryland. The group consist of about twenty scholars and policy experts.

6/16/98

Awarded: Certificate of Appreciation from the Office of the Attorney General, State of Maryland for serving on the Attorney General’s Research Working Group.

9/20/98

Awarded an Honor Award by the National Alliance for the Mentally Ill of Howard County for serving and advocating compassionately for progress in mental health services.

2/98-present

Chairman of the National Conference on: “Research with Persons with Mental Disorders Affecting Decisional Capacity” - Response to the National Bioethics Advisory Commission’s (NBAC) Report, November 13-15, 1998.

April, 1998

Chairman of a Symposium: Forum on Responsible Conduct in Biomedical Research, sponsored by Society for Experimental Biology and Medicine, District of Columbia Section and the Interinstitute Bioethics Interest Group, The National Institutes of Health, The Lister Auditorium, The National Library of Medicine, Title of the Talk: “Introduction to Ethics in Research,” 2-5 PM, Friday, May 1, 1998.

1995 -1998

Member of the Research Working Group of the Office of the Maryland Attorney General (chaired by Jack Schwartz, J.D.) to prepare a report of how the ammend the Health Care Decision Act to include the use of human subjects in Research.

1996

Attended (Invited) and made oral presentation to the Interagency working group to Implement Recommendations of the Advisory Committee on Human Radiation Experiments. February 27, 1996, Washington, D.C.

1995

Member of the Planning Committee of the “Annual Workshop on Ethical Issues in Research,” University of Maryland Graduate School at UMAB, November 8, 1995.

1994

Member of the Planning Committee of the “Annual Workshop on Ethical Issues in Research,” University of Maryland Graduate School at UMAB, November, 1994.

1994-1995

Member of the Planning Committee of the conference on: Ethical Issues in Research Relationships between Universities and Industry” held November 3-4, 1995, Baltimore Marriott, Baltimore, Maryland.

1994-1995

Chairman of the organizing committee of the "First International Conference on Ethics in Neurobiological Research with Human Subjects" held in Baltimore, Maryland in January 7-9, 1995.

1993-1995

Co-Chairman of the organizing committee of the "Fourth Conference on Research Policies and Quality Assurance - Public Perception", Sponsored by Ares-Serona Symposia, held in Monaco June 25-28, 1995.

1994

Member of 20 person group to develop code of ethics for the participant in series, demonstration and research conducted by Substance Abuse and mental Health Services Administration (SAMHSA). The conference title: "Annapolis participant Protection conference.

6/1994

Awarded the Distinguished Service Award by the Alliance for the Mentally Ill of Maryland.

2/1994

Awarded the 1994 Advocacy award by Mental Health Association of Maryland during the annual dinner, Lowe, Annapolis Hotel, Feb. 8, 1994.

1993

NAMI/NIMH sponsored meeting on Informed consent for persons with mental illness. Attended by NIMH and NAMI leaderships (15 persons). Conference held at NAMI Headquarters, Arlington, VA.

1991-1993

Member of the Organizing Committee of "The Challenge of Biotechnology, from Laboratory Diagnosis to Clinical Therapy", sponsored by Ares-Serona Symposia, Rome, Italy, Oct., 1993.

1991 - 1993

Co-chairman of the organizing Committee of the "Third Conference on Research Policies and Quality Assurance-Government Regulations" Baltimore, MD., May 2-5, 1993.

1991-Present

Member of the NAMI "Science Review Committee" of the National Alliance for the Mentally Ill (NAMI).

1992

Member of the State of Maryland, Governors Health Care Summit, Annapolis, MD

1990-1991

Member of the organizing committee of "Biotechnology of Cell Regulation" University of Siena, Siena, Italy, sponsored by Ares-Serona Symposia, June 20-22, 1991.

1989-1991

Chairman of the organizing Committee of the "Second International Conference on Research Policies and Quality Assurance." Sponsored by Ares-Serona Symposia, May 6-7, 1991, Rome, Italy.

1987-1990

Member of the organizing committee of the fourth international workshop on "Calcium and Phosphate in Health and Disease" Leon, France, March 8-10, 1990.

1990

Member of the "Workshop on Data Management in Biomedical Research: Co-Chairman of the session on "Data Ownership" sponsored by the Office of Integrity in Research of the Public Health Service.

7/85-6/89

Member, Scientific Council, Maryland Academy of Sciences

2/86-1/89

Council member, Biophysical Society.

1988

Member of the "Workshop on the Responsible Conduct of Research in Health Sciences" sponsored by the National Academy of Sciences, Institute of Medicine, Washington, D.C.

9/22/88

Member of the "Workshop on Bioengineered Molecules: Basic and Clinical Aspects" held by Ares-Serona Symposia, Rome, Italy.

9/19-9/20/88

Member of the International Symposium on "Advances in Biotechnology of Membrane Ion Transport", Aula Maga dell University, A'Aquilla, Italy.

7/88

Member of the State of Maryland, Department of Education Site Visit Evaluation Team to "Maryland Summer Center for Critical and Creative Thinking" at St. Marys' College.

1987-88

Chairman of a Symposium on "Tertiary Structure of (Ca2+ + Mg2+)- ATPase," with the International Society for Heart Research, June 26-28, 1988, Williamsburg, VA.

1987 - 1988

Chairman of the Organizing Committee of the "First International Conference on Scientific Data Audit Policies and Quality Assurance," May 8-10, 1988, University of Maryland, College Park, MD.

1986-87

Member of the organizing committee of the First International Conference of Membrane Biophysics Group of the Biophysical Society on "Regulation of Transport Mechanisms," September 27-30, 1987, Beaufort, NC.

4/86-4/87

Chairman, Committee on Programs and Exhibits for the Maryland Academy of Sciences.

2/84-2/86

Member, K.C. Cole Membrane Award Committee of the Biophysical Society.

1/83-2/85

Secretary/Treasurer, Membrane Biophysics Group of the Biophysical Society.

2/83-2/84

Chairman, K.C. Cole Membrane Award Committee of the Biophysical Society.

2/82-2/83

Chairman, Membrane Biophysics Sub-group of the Biophysical Society.

6/80-6/81

Member of the Executive Committee of the BioenergeticSub-group of the Biophysical Society.

1980-1980

Conference Chairman of the organizing committee of the International Conference on "Carriers and Channels in Biological Systems - Transport Proteins" sponsored by the New York Academy of Sciences, held February 4-5, 1980 in New York City.

6/79-6/80

Co-chairman of the Bioenergetics Sub-group of the Biophysical Society.

1975-76

Conference Chairman of the organizing committee of the Ninth Rochester International Conference on Environmental Toxicity - Membrane Toxicity, Rochester, NY, held May 24-26, 1976.

1974-75

Conference Chairman of the organizing committee of the International Conference on "Carriers and Channels in Biological Systems" sponsored by the New York Academy of Sciences, New York, NY, held February 24- 27, 1975 in New York City.

9/71-8/72

Secretary of the Mount Sinai School of Medicine of the City University of New York, Chapter of the American Association of University Professors, New York, NY.

6/71-7/72

Basic Science Faculty Representative on the Executive Faculty Committee of the Mount Sinai School of Medicine of the City University of New York. Voted in by a secret ballot election.


Academic & Professional Honors:   top

June 1964-June 1965 Graduate Fellowship from Engineering Physics Department, University of Louisville, Louisville, KY,.

June 1967-October 1967. Training Fellowship, NIH, from University of Louisville School of Medicine, Louisville, KY,

July 1976-June 1979 Established Investigatorship of the American Heart Association.

Summer 1977 Neuroscience Research Program Fellowship (Two weeks intensive study Program) Boulder, CO.

HONOR SOCIETIES  
 Sigma Pi Sigma 4/65
 Phi Kappa Phi 3/66
 Sigma Xi 4/71

PROFESSIONAL SOCIETIES

10/03-present

Member, ACRP

11/97-present

Charter Member, American Society of the Bioethics and Humanities.

1994-present

Member, World Federation for Mental Health

3/94-present

Associate Member, The Hastings Center

5/93-11/97

International Bioethics Institute

6/91-6/94

Applied Research Ethics National Association (ARENA)

5/89-6/94

Society of Quality Assurance

5/89-present

American College of Sports Medicine

7/87-present

Member of the Council of Biology Editors

1/81-7/95

Member of the International Society for Heart Research

6/78-7/95

Member of Basic Science Council of American Heart Association

6/78-present

American Society of Biological Chemistry and Molecular Biology

6/75-7/97

Member of the U.S. Bioenergetics Group of the Biophysical Society

7/73-7/95

New York Academy of Sciences

6/71-6/95

Charter Member of "Membrane Biophysics Group" of the Biophysical Society

4/71-present

American Physiological Society

6/70-present

American Association for Advancement of Science

1/70-present

Biophysical Society

1/66-7/73

American Association of Physics Teachers

6/85-10/89

International Society for the Study of Xenobiotics


Journals, Editorials, Reviews, etc.:  top

 

4/2005 - Present

Member, Editorial Board of: Drug Information Journal.

1/2003-present

Member, Advisory Board of:  Clinical Trials Compliance.

9/2003-present

Member, Advisory Board of:  Bioresearch Monitoring Alert.

1996 -present

Editorial Board Member of: Technology Management

1987-present

Founder and Editor-in-Chief of the journal "Accountability in Research" Gordon and Breach Science Publishers, Inc., New York

1977-1984

Co-founder and Co-Editor-in-chief of "Membrane Biochemistry," an international Journal of Biochemistry and Biophysics of Membranes. Taylor & Francis Publishers, New York.

1984 - 1993

Editor-in-Chief of above Journal

1990-present

Editorial Board Member of: Quality Assurance: Good Practice, Regulation, and Law, Academic Press, New York, N.Y., USA

1987-1994

Editorial Board Member, Molecular and Cellular Biochemistry, Martinus Nighoff Publishers,

1985-1995

Reviewer for the following journals: J. Membrane Biology; Science; J. General Physiology; Anal. Biochemistry; J. of Neurochemistry; Biochim. Biophys. Acta; Archives of Biochemistry and Biophysics; J. Biol. Chem.; Biochemistry.

1992-1995

Grant reviews, site visits, and study sections for NIH, NSF, Department of Energy (DOE), Office of Naval Research, US-Israel BSF, and the American Heart Association-Maryland Affiliate. Recent: Jan. 29, Ad-hoc NIEHS Contract review committee on quality assurance proposals.

 

 


BIBLIOGRAPHY

BOOKS - EDITORSHIP AND AUTHORSHIP   top

15.      Shamoo, A. E., and Resnik, D. B. (2003), “Responsible Conduct of   
Research”, pp. 1-345, 2003, Oxford University Press.

14. Shamoo, A. E., and Khin-Maung-Gyi, F. A., (2002) Monograph on : “ Ethics of the Use of Human Subjects in Research”, pp. 1-120, Garland Publishing.

13. Shamoo, A.E., and Moreno, J., Editors (2000), “Business and Research,” Proceedings of the third National Conference on the Business of Human Experiments:  Ethical, Legal, and Regulatory Issues, November 3-5, 2000, Baltimore, Maryland, pp. 1-140, Taylor & Francis, New York.

12. Shamoo, A.E., Editor (1998),  Proceedings of a National Conference on:  Research and Decisional Capacity—Responding to the National Bioethics Advisory Commission,” Baltimore, Maryland, Nov. 13-15, 1998, pp. 1-249, Taylor & Francis, New
 York.

11. Rogers, M.A., Wernicki, P.G., and Shamoo, A.E., (2000) Sport Medicine for Coaches and Athletes - Older Individuals and Athletes Over 50," pp. 1-136, Harwood Academic Publishers.

10. Ekeland, A., Crockett, L.J. and Shamoo, A.E. (2000), "Sport Medicine for Coaches and Athletes - SKIING," pp. 1-136, Harwood Academic  Publishers, Switzerland.

9. Shamoo, A.E., Silberstein, C.E., and Germeroth, R.M. (2000), "Sport Medicine for Coaches and Athletes - BASEBALL," pp. 1-135, Harwood Academic Publishers, Switzerland.

8. Shamoo, A.E.,  (1997).  Editor, “Ethics in Neurobiological Research with Human
   Subjects” pp. 1-335, Gordon and Breach Publishers OPA, Amsterdam, B.V.,
The Netherlands.

7. Shamoo, A.E., Baugher, W.H., and Germeroth, R.M. (1995).  “Sports Medicine for
 Coaches and Athletes - SOCCER.”  pp. 1-115, Harwood Academic Publisher,
 New York, N.Y., USA.

6. R. Verna and A. Shamoo, Editors (1994).  Co-Editor, “Biotechnology Today - Challenges
of Modern Medicine,” Vol. 5, pp. 1-280.

5. Shamoo, A.E., Editor (1989).  "Principles of Research Data Audit," Gordon and Breach
Science Publishers, Inc., pp. 1-181, New York, .

4. Shamoo, A.E., Editor (1975).   Carriers and Channels in Biological Systems.  Ann. New
York Acad. of Sciences 264,  pp. 1-485.

3. Shamoo, A.E., Editor (1977).  Membrane Toxicity, Plenum Press, New York, p. 1

2. Shamoo, A.E., Editor (1980).  “Carriers and Channels in Biological Systems – Transport Proteins.”  Ann. New York Acad. of Sciences 358.

1. Shamoo, A.E., Editor (1985).  “Regulation of Calcium Transport Across Muscle Membranes – Current Topics in Membranes and Transport,” Vol. 25, Academic Press, New York.

 

Articles (Since 1985)
206.     Shamoo, A. E. (2005), “The Need for Better Reporting of Adverse Events for Human Subjects in Research”, DIA Today, April 2005, Volume 5, Issue 2, p. 18, 20.
205.     Resnik, D. B. and Shamoo, A. E., (2005) “ Bioterrrorism and the Responsible Conduct of Research”, Commentary, Drug Development Research, 63:121-133.
204.   Shamoo, A. E. and Cole, J. (2004), “Ethics of Genetic Modification of Behaviour”, Accountability in Research, 11:201-214.
203.     Shamoo, A. E. and Strause, L. (2004) “Closing the Gap in Regulations for the Protection of Human subjects in Research”, Monitor, Spring 2004, chosen as cover story.
202.     Shamoo, A. E. and Moreno, J. (2004) “ A Response to Commentators on “Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon”, American Journal of Bioethics 4:W 29.
201.     Shamoo, A.E. and Moreno, J. (2004), “Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon,” American Journal of Bioethics 4:25-31, (Chosen as a Target Article with 13 commentaries).
200.     Shamoo, A.E., and Cole, J.W. (2004), “Fear of Influence - Conflict of Interest in Biomedical and Genetic Research,” In: GenWatch 13:12-13, July-August (Both in the magazine and website).
199.     Shamoo, A.E. (2005), “Accountability in Research,” In:  Encyclopedia of Science, Technology, and Ethics, edited by Carl Mitcham, Macmillan Publishing Company.
198.     Shamoo, A.E. (2003), “A Perspective on Current Events in Vaccine Development,” In: Vaccine Technology and Development News, 2(7):10-12.
197.     Shamoo, A.E., and Campbell, J.D., (2003), “The Use of Experimental Drugs During National Crises,” Accountability in Research, 10:69-84, 2003.
196.     Shamoo, A.E., and Tauer, C.A. (2002), “Ethically Questionable Research with Children:  The Fenfluramine Study,” Accountability in Research, 9:143-166,2002.
195.     Shamoo, A.E. (2002), “Ethically Questionable Research with Children.  The Kennedy Krieger Lead Abatement Study,” Accountability in Research, 9:167-175, 2002.
194.     Shamoo, A. E. (2002), “Moral and Compliance Issues in Clinical Research- Part 1, Where We Are Today, RAPS RA Interactive (pp1-2), http:///www.raps.org/rainteractive/articleCT.cfm?article_ID=63, Part 2, Future Challenges, RAPS RA Interactive (pp1-2, http:///www.raps.org/rainteractive/articleCT.cfm?article_ID=70
193.     Shamoo, A.E., Krimsky, S., and Resnik, D.B., (2002), “Editorial,” Accountability in Research, 8:281-282.
192.     Shamoo, A.E. (2001), “Adverse Events Reporting – The Tip of an Iceberg,” Accountability in Research, 8:197-218.
191.     Shamoo, A. E. (2000), “ Editorial: The Ethical Import of Cold Fusion Controversy”, Accountability in Research, 8:i-iv.
190.     Sharav V. H., and Shamoo, A. E. (2000), “ Lab Rats- Why do people who participate in clinical studies have fewer protections than animals”, Salon.Com, August 21, (http://www.salon.com/health/feature/2000/08/18/human_subject.htm)
189.     Shamoo, A. E. and Cheryl Dunigan (2000), “ Ethics in Research”, Experimental Biology and Medicine 224:205-210.
188.     Sharav, V. H., and Shamoo, A. E. (2000), "Are Experiments That Chemically Induce Psychosis In Patients Ethical?”, BioLaw, II, No.1: S1-S36.
187.     Shamoo, A.E. (2000), " Future Challenges to Human Subject Protection", The Scientist, June 26, 35-35.
 186.          Shamoo, A.E. (2000),  “Ethics of High Risk Psychiatric Research,” Winter Trauma,  pp. 13 & 14.
185.     Shamoo, A.E. (1999), "Critique of the Recommendations of the National Bioethics     Advisory Commission's Report on Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity," BioLaw II, Nos. 9 & 10:S439-S444.
 184.          Sharav, V.H. and Shamoo, A.E. (1999).  “Unethical Human Experiments in Unwitting Patients,” Statement for the Record submitted to U.S. Senate Sub-Committee, Public Health and Safety of the Senate Health, Education, Labor and Pensions Committee, February 2, 2000.
 183.          Shamoo, A.E. (1999).  “The need for better protections for vulnerable groups when used in research experiments,” Testimony to Subcommittee on Criminal Justice, Drug Policy, and Human Resources, Committee on Government Reform, U.S. House of Representative, United States Government, December 9, 1999, hearing held at New York Lawyers Association, New York, N.Y.
 182.          Shamoo, A.E. (1999).  “Institutional Review Boards (IRBs) and Conflict of Interest,” Accountability in Research 7:201-212.
 181.          Shamoo, A.E. (1999).  Book Review of “Ethics in Psychiatric Research: A Resource Manual for Human Subjects Protection,” Edited by Pincus et al., Washington, D.C. APA Press, 1999, XIX & 341 pp., Journal of Nervous and Mental Disease 187:644-645.
180.     Shamoo, A.E. (1999).  “Unregulated Research with Human Subjects,” Accountability in Research 6:205-214.
179.     Shamoo, A.E. (1998).  “Scientific Evidence and the Judicial System,” (pp. 1-13), In:  Scientific Evidence Review, Monograph No. 3, American Bar Association, Section of  Science and Technology.  This is the same paper as Shamoo (1995) in Accountability in Research.
178.     Shamoo, A.E. and O’Sullivan, J.L. (1998), “The Ethics of Research on the Mentally Disabled,” Chapter 21 in “Health Care Ethics - Critical Issues for the 21st Century” Editors, J.F. Monagle, and D.C. Thomasma, pp. 239-250, Aspen Publishers, Gaithersburg, Maryland.
177.     Shamoo, A.E. and Sharav V.H. (1997). “Unethical Use of Persons with Mental Illness in High Risk Research Experiments,” BioLaw II:S23-S31.
176.     Rule, J.T. and Shamoo, A.E. (1997).  “Ethical Issues in Research Relationships Between Universities and Industry,” Accountability in Research 5:239-250.
175.     Shamoo, A.E., Irving, D.N., and Langenberg, P. (1997).  “A Review of Patient Outcomes in Pharmacological Studies from the Psychiatric Literature, 1966-1993,” Science and Engineering Ethics, 3:395-406.
174.     Shamoo, A.E. (1997).  “The Unethical Use of Persons with Mental Illness in High Risk Research Experiments,” Testimony to Human Subjects Subcommittee of the National Bioethics Advisory Commission, July 15, 1997.  Appears in NBAC website and publications.
173.     Shamoo, A.E. and Sharav, V.H. (1997).  “The Unethical Use of Persons with Mental Illness in High Risk Research Experiments” Testimony to National Bioethics Advisory Commission, Jan. 9, 1997.  Appears in NBAC website and publication.
172.     Shamoo, A.E. (1997).  “Letter to the Editor,” IRB, A Review of Human Subject Research, 19:10.
171.     Shamoo, A.E., Johnson, J.R., Honberg, R. and Flynn, R. (1997).  “NAMI’s Standards for Protection of Individuals with Severe Mental Illnesses who Participate as Human Subjects in Research,” Chapter 32, pp. 325-328, in “Ethics in Neurobiological Research with Human Subjects,” Shamoo, A.E., Editors, Gordon and Breach Publishers.
170.     Shamoo, A.E. (1997).  “Ethical Considerations in Medication-Free Research on the Mentally Ill,” Chapter 17, pp. 195-200 in “Ethics in Neurobiological Research with Human Subjects,” Shamoo, A.E., Editor, Gordon and Breach Publishers.
169.     Irving, D.N. and Shamoo, A.E. (1997).  “Washout/Relapse in Patients Participating in Neurobiological Research Studies in Schizophrenia”, Chapter 7, pp. 119-128 in “Ethics in Neurobiological Research with Human Subjects,” Shamoo, A.E., Editor, Gordon and Breach Publishers.
168.     Shamoo, A.E. and Cassidy, M.E. (1997).  Conference Summary,pp. 5-26, In “Ethics in Neurobiological Research with Human Subjects” Shamoo, A.E., Editor, Gordon and Breach Publishers.
167.     Shamoo, A.E. (1997).  “Introduction - Conference speech as a Chairman of the First National Conference on “Ethics in Neurobiological Research with Human Subjects” Shamoo, A.E., Editor, pp. 1-3, Gordon and Breach Publisher.
166.     Shamoo, A. E. (1997).  “Attempts At Suppressing Data”, Professional Ethics Reports, of the AAAS, Volume X, Number 1, p.3-6, including two rebuttals.
165.     Shamoo, A.E. (1997).  “The ethical import of creation.”  The Baltimore Sun, Perspective, Sunday, March 2, Section F, 7F (Invited).  Also, the article was carried by the Memphis Times, Sunday, March 9, 1997, p.B4.
164.     Shamoo, A.E. (1997).  “Brain Disorders -- Scientific Facts, Media, and Public Perception”, Accountability in Research 5:161-174.
163.     Shamoo, A.E. and Boursin, J.L. (1997).  “Introduction”, Accountability in Research 5: i-ii.
162.     Zucker, C., Lowenkron, R. and Shamoo, A.E. (1997).  “Research on Children.”  Letter to the Editor, The New York Times, Tuesday, January 7th, p. A15.
161.     Shamoo, A.E. (1996).  “The Inhumane Use of Persons with Mental Illness in Biomedical Experimental Research” In proceeding of:  Human Radiation Experiments, S. Hrg. 104-588, Hearing before the Committee on Governmental Affairs, United States Senate, March 12, 1996, pp. 63-73, Superintendent of Documents, Congressional Sales Office, Washington, D.C.  20402.
160.     Shamoo, A.E. and Keay, T. (1996).  "Ethical Concerns about Relapse Studies" -  Cambridge Quarterly of Health Care Ethics, 5:373-386.
159.     Shamoo, A.E. (1996).  “Mental illness is real disease of the Brain.”  Editorial, The Baltimore Sun, Sunday, September 1,  P. 2F.
158.     Shamoo, A.E. (1996).  “Human Rights in Reference to Persons with Mental Illness,” Accountability in Research 4:207-216.
157.     Dunigan and Shamoo, A.E. (1996).  “Identification of the Major Transport Pathway for the Parkinsonism Inducing Neurotoxin 1-Methyl-4-Phenylpyridinium” Neuroscience, 1996, 75:37-41.
156.     Dunigan and Shamoo, A.E., “Cation Requirement of Basal and ATP- Regulated Dopamine Transport in Rat Pheochromocytoma (PC12) Cells.” Neuroscience, 74:275-282, 1996.
155.     Shamoo, A.E. (1995).  “Scientific Evidence and The Judicial System” Accountability in Research 4:21-30.
154.     Eshleman, C. Dunigan, A. Shamoo, and M. Elderfrawi  (1995).  “ATP Enhances Catecholamine Uptake into PC12 Cells” Life Science, 56:1613-1621.
153.     Glick, J.L. and Shamoo, A.E. (1994).  "Results of a Survey on Research Practices, Completed by Attendees at the Third Conference on Research Policies and Quality Assurance."  Accountability in Research 3:275-280.
152.     Doucet, S., Bridge, A., Grimlund, R.A., and Shamoo, A.E. (1994).  "An Application of Stratified Sampling Techniques for Research Data." Accountability in Research 3:237-248.
151.     Shamoo, A.E. (1994).  "Editors, Peer Reviews, and Ethics," Perspectives, 14:4-5.
150.     Shamoo, A.E. (1994).  "Our Responsibilities Toward Persons with Mental Illness as a Human Subjects in Research" The Journal of the California Alliance for the Mentally Ill, 5:14-6.
149.     Shamoo, A.E. and Stewart, B. (1994).  "Maryland Leads Country in Ending Insurance Discrimination."  NAMI Advocate 15, March/April, 1 and 3.
148.     Shamoo, A.E.  (1994).  A member of one half hour show in a series on "Biotechnology Today". Segmement on Bioethics. Public Broadcasting System(PBS), March-April,1994.
147.     Shamoo, A.E., (1994).  "Mental Health Care: It's Needed and It Works". The Baltimore Sun, OP-Ed. article, Feb.9,11A.
146.     D. Dunigan, and Shamoo, A.E. (1994).  " Li+ Stimulates ATP-Regulated Dopamine Uptake in PC12 Cells"  Neuroscience, 65:1-4.
145.     Shamoo, A.E. and Glick, J. Leslie (1994).  "Luminescence Spectroscopy in Dementia Diagnosis"  In, "Biotechnology Today" in Challenges of Modern Medicine, Vol. 5, R. Verna and A. Shamoo, editors.  pp. 11-22, Ares-Serono Symposia Publications.
144.     Irving, D.N. and Shamoo, A.E. (1993).  "Which Ethics for Science and Public Policy", Accountability in Research, 3:77-100.
143.     Shamoo, A.E. and Irving, D.N. (1993).  "Accountability in Research Using Persons With Mental Illness" Accountability in Res., 3:1-17.
142.     Shamoo, A.E. and Irving, D.N. (1993).  "The PSDA and the Depressed Elderly: "Intermittent Competency" Revisited. The Journal of Clinical Ethics 4:74-80.
141.     Glick, J.L and Shamoo, A.E. (1993).  "A Call For the Development of "Good Research Practices" (GRP) Guidelines" Accountability in Research 2:231-235.
140.     Shamoo, A.E. (1993).  "Role of Conflict of Interest in Public Advisory Councils", Chapt. 17, pp. 159-174 in "Ethical Issues in Research", edited by D. Cheney, University Publishing group, Inc. Frederick, Maryland 21701.
139.     Lockwich, T., Dunigan, C.D. and Shamoo, A.E. (1993).  "Uncoupling of  Occlusion from ATP Hydrolysis Activity in Sarcoplasmic Reticulum."  Membrane Biochemistry, 10:191-201, 1993.
138.     Lockwich, T., Ambudkar, I.S.and Shamoo, A.E. (1993).  "Ca2+-Permeability of Rat Parotid Gland Basolateral Plasma Membrane Vesicles is Modulated by Membrane Potential and Extravesicular [Ca2+] "  Membrane Biochemistry, 10:171-180.
137.     Shamoo, A.E. (1992).  "Role of Conflict of Interest in Scientific Objectivity - A Case of a Nobel Prize Work.  Accountability in Research, 2:55-75.
136.     Shamoo, A.E. (1992).  "Introductory Remarks "Accountability in Research, 2:i-ii.
135.     Shamoo, A.E. (1992).  "The Use of the Mentally Ill in Research" - Report to the National Alliance for the Mentally Ill (NAMI).  An internal report for NAMI upon re    from the NIMH Research Monitoring Committee.  A thorough and detailed study (2 years) of the issue.
134.     Shamoo, A.E. (1991).  Editorial on:  "Quality Assurance and Regulation", Regulatory Toxicology and Pharmacology, 14:1-2.
133.     Shamoo, A.E. (1991).  "Quality Assurance", Quality Assurance:  Good Practice, Regulation,and Law 1:4-9.
132.     Shamoo, A.E. (1991).  "Integrity in Science" Text of a speech appeared in the Proceedings of the 11th Annual National Meeting on Managing Environmental Data Quality, Dallas, Texas, April 22-26.
131.     Shamoo, A.E. and Cassidy, M.M. (1991).  "Integrity of Scientific Enterprises"  Letter to the Editor, FASEB Journal 5: 2869-2870.
130.     Glick, J.L. and Shamoo, A.E. (1991).  "Auditing Biochemical Research Data:  A Case Study."  Accountability in Research, 1:223-243.
129.     Shamoo, A.E. (1991).  "Policies and Quality Assurance in the Pharmaceutical Industry."Accountability in Research, 1:273-284.
128.     Lockwich, T. and Shamoo, A.E. (1991).  "Tertiary Structure of Sarcoplasmic (Ca2+ + Mg2+)-ATPaseUsing Eu3+ Luminescence Techniques:  "Implications on Energy Coupling" In "Biotechnology of Cell Regulation", Serono Symposia Series Advances in Experimental Medicine, Vol. 4, Editors: R. Verna and Y. Nishizuka, pp. 23-33, Raven Press, New York.
127.     Cao, C.J., Lockwich, T., Scott, T.L., Blumenthal, R., and Shamoo, A.E. (1991).  "Uncoupling of Ca2+-Transport from ATP Hydrolysis Activity of Sarcoplasmic Reticulum (Ca2+ + Mg2+)-ATPase.  Molecular and Cellular Biochemistry, 103:97-111.
126.     Shamoo, A.E. and Teaff, R. (1990).  "Data Ownership."  CBE Views, 13:112-114.
125.     Lockwich, T.P. and Shamoo, A.E.  (1990).  "Identification of a spectroscopic  Marker for the Ca2+-Binding Site of (Ca2+ + Mg2+)-ATPase of Sarcoplasmic Reticulum in the Occluded State."  Membrane Biochemistry 9:61-67.
124.     Shamoo, A.E., Lockwich, T., Cao, C.J., and Douglas, C. (1990).  "Tertiary Structure of the Muscle Pump." In "Calcium Transport and Intracellular Calcium Homeostasis," Conference Proceedings.  March 4-7, 1990, pp. 73-86.  Editors: D. Pansu and F. Bronner, Springer-Verlag. ss.
123.     Shamoo, A.E., Lockwich, T., and Cao, C. (1990).  "Tertiary Structure and Energy Coupling in Ca2+-pump System."  Molecular and Cellular Biochemistry 99:67-74.
122.     Cao, C., Shamoo, A.E., and Eldefrawi, M.E. (1990).  "Cocaine-Sensitive, ATP-Dependent Dopamine uptake into striatal synaptosomes." Biochemical Pharmacology, 39: pp. R9-R14, 1990.
121.     Shamoo, A.E. (1989).  "A Note from the Editor," Accountability in Research, 1:i-ii,.
120.     Cassidy, M.M. and Shamoo, A.E. (1989).  "Prologe:  First International Conference on Scientific Data Audit, Policies and Quality Assurance", Accountability in Research, 1:1-3.
119.     Loeb, S.E. and Shamoo, A.E. (1989).  "Data Audit:  Its Place in Auditing," Accountability in Research, 1:23-32,1989.  Also appeared in:  Principles of Research Data Audit, Editor:  A. Shamoo, pp. 13-26, Gordon and Breach Science Publishers, Inc., New York.
118.     Shamoo, A.E. and Annau, Z. (1989).  "Data Audit - Historical Perspective" Chapter 1, in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp.1-12, Gordon and Breach Science Publishers, Inc. New York.  Also appeared in Accountability in Research, 1:87-96, 1990.
117.     Shamoo, A.E. and Davis, S. (1989).  "The Need for Integration of Data Audit into Research and Development Operations" Chapter 3, in: Principles of Research Data Audit, 1989, Editor:  A.E. Shamoo, pp.27-38, Gordon and Breach Science Publishers, Inc. New York.  Also appeared in: Accountability in Research, 1:119-128, 1990.
116.     Shamoo, A.E. (1989).  “Organizational Structure and Function of Research and Development,” Chapter 4 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 39-63, Gordon and Breach Science Publishers, Inc. New York.
115.     Shamoo, A.E. (1989). Suggested standards for Data Audit," Chapter 6 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 73-78, Gordon and Breach Science Publishers, Inc. New York.
114.     Shamoo, A.E. (1989).  "Auditing Laboratory Based Data," Chapter 7 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 79-93, Gordon and Breach Science Publishers, Inc. New York.
113.     Glick, L. and Shamoo, A.E. (1989).  "Data Audit as a Management Tool," Chapter 8 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 95-109, Gordon and Breach Science Publishers, Inc. New York.
112.     Shamoo, A.E. and Glick, L. (1989).  "Federal Regulations," Chapter 10 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 121-135, Gordon and Breach Science Publishers, Inc. New York.
111.     Shamoo, A.E. and Hardy K. (1989).  "Ethical and Legal Responsibility," Chapter 13 in: Principles of Research Data Audit, Editor:  A.E. Shamoo, pp. 171-174, Gordon and Breach Science Publishers, Inc. New York.
110.     Shamoo, A.E. (1988).  Safeguarding The Scientific Enterprise", Maryland In Baltimore 2 (#3) 32-32.
109.     Shamoo, A.E. (1988).  "We Need Data Audit." The AAAS Observer, Supplement to Science Magazine, Nov. 4, P.4.
108.     Shamoo, A.E. and T.R. Herrmann (1988).  "Tertiary Structure of the (Ca(II) + MG(II))-ATPase Probed By Laser-Pulsed Lanthanide Luminescence Spectroscopy".  In Proceedings of International Symposium on "Advances in Biotechnology of Membrane Ion Transport", held September 19-20, 1988 in Aula Maga dell' University, A'Aquila, Italy, p. 125-133.  P.L. Jorgensen and Robert Verna, eds., Serono Symposia Vol. 51. Raven Press.
107.     Joshi, N.B. and A.E. Shamoo (1988).   Distances between functional sites in cardiac sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase.  Interlanthanide energy transfer, Eur. J. of Biochemistry 178: 483-487.
106.     Herrmann, T.R. and A.E. Shamoo (1988).  "Estimation of Inter-binding-site Distances in Sarcoplasmic Reticulum (Ca2+ + Mg2+)-ATPase Under Occluded and Non-occluded Conditions", Molecular and Cellular Biochemistry 8: 55-58.
105.     Shamoo, A.E., N.B. Joshi, and T. Lockwich (1988).  "Regulation of Cardiac Sarcoplasmic Reticulum", Molecular and Cellular Biochemistry 8: 45-50.
104.     Ambudkar, I.S., E. Abdallah, and A.E. Shamoo (1988). "Lysophospholipid-Mediated Alterations in the Calcium Transport Systems of Skeletal and Cardiac Muscle Sarcoplasmic Reticulum", Molecular and Cellular Biochemistry 7: 81-89.
103.     Shamoo, A.E. and Z. Annau (1987).  "Ensuring Scientific Integrity", correspondence.  Nature 327: 550, 1987.
102.     Shamoo, A.E., T.R. Herrmann, P. Gangola, and J.B. Joshi. (1988).  Biophysical aspects of Ca2+-transport sites in skeletal and cardiac sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase, pp. 221-241.  In: Proceeding of the "Symposium on Heart Metabolism in Health and Disease" July 8-11, 1986.  Winnipeg, Canada.  N.S. Dhalla, Grant N. Pierce and Robert E. Beamish, Martinus Nighoff/Dr. Junk Publisher, eds.
101.     Mansour, N.A., J.J. Valdes, A.E. Shamoo, and A. Annau (1987). "Biochemical Interactions    of Carbamate and Ecothiophate with the Activated Conformation of Nicotinic Acetylcholine Receptor,"  J. Pesticide Biochem. Toxicol. 2: 25-42.
100.     Shamoo, A.E. and N.B. Joshi (1987).  Regulation of the peptide region of the calcium and ATP sites of the calcium pump protein.  In Progress in Clinical and Biological Research:  Proceedings of the Third International Workshop on "Calcium and Phosphate Transport Across Biomembranes" Vienna, Austria, March 1-4, 1987.  Bronner, F. and Peterlik, M., eds., Alan Liss Inc. Publishers, New York, NY, 252:141-148.
99.       Morsy, F.A., E.A.M. Abdallah, and A.E. Shamoo (1987).  "The Role of  Sulfhydryl Groups in Rat Brain Muscarinic Receptor Binding Sites", Alex. Sci. Exch. 8:73-87.
98.       Shamoo, A.E. (1987).  Biological target sites of mercurials.  Chapter 2, pp. 13-23, C.U. Eccles and Z. Annau, eds.  In "The Toxicity of Methyl Mercury.  Johns Hopkins University Press, Baltimore, MD.
97.       Gangola, P. and A.E. Shamoo (1987).  Characterization of (Ca2+ + Mg2+)-ATPase of sarcoplasmic reticulum by laser-excited europium luminescence.  Eur. J. Biochemistry 162: 357-363.
96.       Joshi, N.B. and A.E. Shamoo (1987).  Binding of Eu3+ to cardiac sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase-laser excited Eu3+ spectroscopic studies.  Biophys. J. 51:185-191.
95.       Abdallah, E.A.M., A.S.A. Abdelfattah, F.A. Morsy, and A.E. Shamoo (1986).  "Influence of Methylmercury  and Mercuric ChloridBrain Muscarinic Acetylcholine Receptors."  J. Egypt. Soc. Toxicol. 3: 91-106.
94.       Mansour, N.A., A.E. Shamoo,  J.J. Valdes, and Z. Annau (1986).  Functional integrity of the acetylcholine receptor reconstituted into lipid membranes. CDRC, Conference Proceedings.
93.       Ambudkar, I.S., D.T. Fanfarillo, and A.E. Shamoo (1986). Phospholamban involvement in the maintenance of basal calcium transport in cardiac sarcoplasmic reticulum.  Membrane Biochemistry 6: 327-346.
92.       Shamoo, A.E. (1986).  Mn(II) and Ca(II) transport in mitochondria, Chapter 5, pp. 65-80, In:  "Manganese in Metabolism and Enzyme Function",  V.L. Chramm and F.C. Wedler, eds.  Academic Press, San Diego, CA.
91.       Herrmann, T.R., A.R. Jayaweera, and A.E. Shamoo (1986).  Interaction of Europium (III) with phospholipid vesicles as monitored by laser-excited Europium (III) luminescence.  Biochemistry 25: 5834-5838.
90.       Herrmann, T.R., P. Gangola, and A.E. Shamoo (1986). Estimation of inter-binding sitedistances in sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase using Eu (III) luminescence energy transfer.  Eur. J. Biochemistry 158: 555-560.
89.       Gangola, P. and A.E. Shamoo (1986).  Synthesis and characterization of peptide segment of (Ca2+ + Mg2+)-ATPase - A candidate for Ca2+ transport site.  J. Bio. Chem. 261: 8601-8603.
88.       Jacobson, M.S., M.G. Price, A.E. Shamoo, and F.P. Heald (1985). Atherogenesis in white carneau pigeons:  Effects of low level cholestane triol feeding. Atherosclerosis 57: 209- 217.
87.       Shamoo, A.E., I.S. Ambudkar, M.S. Jacobson, and J. Bidlack, J. (1985).  Regulation of calcium transport in cardiac sarcoplasmic reticulum.  In Regulation of Calcium Transport Across Muscle Membranes.  Current Topics in Membranes and Transport, Vol. 25: 131-145.  A. E. Shamoo, ed.  Academic Press, New York, NY.
86.       Shamoo, A.E. (1985).  Overall regulations of calcium transport in muscle.  In Regulation of Calcium Transport Across Muscle Membranes.  Current Topics in Membranes and Transport, Vol. 25: 1-7.  A. E. Shamoo, ed., Academic Press, New York, NY.
85.       Morsy, F.A. and A.E. Shamoo (1985).   Trans-magnesium dependency of ATP-dependent calcium uptake into sarcoplasmic reticulum of skeletal muscle.  Magnesium 4: 182-187.
84.       Movsesian, M.A., I.S. Ambudkar, R.S. Adelstein, and A.E. Shamoo (1985).   Stimulation of canine cardiac sarcoplasmic reticulum Ca2+-antagonists.  Molecular Pharmacology 34:195-201.
83.       Jacobson, M.S., I.S. Ambudkar, S.A. Naseem, F.P. Heald, and A.E. Shamoo (1985).  Cardiac sarcoplasmic reticulum:  Effect of an atherogenic diet, during the neonatal and juvenile periods.  Atherosclerosis 55: 81-91.
82.       Shamoo, A.E. and I.S. Ambudkar (1985).  Resolution of the regulatory systems of the cardiac sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase.  In "Structure and Function of Sarcoplasmic Reticulum" Conference proceedings of a meeting in Kobe, Japan, July 4-10, 1982, pp. 577-590.  Fleisher and Tonomura, eds., Academic Press, NY.
 

PATENTS

1.     Shamoo, Adil E., "Liquid Scintillators".  U.S. Department of Commerce Patent

Office, Serial No. 158554, 1972.